Clinical Trials Browser

OTHER × Leukemia, B-Cell × Lenalidomide × Clear all

NCT06762431 2025-01-07

VTB-CLL002

Phase 1/2 Enrolling by invitation

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01400685 2018-01-25

Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00751296 2016-06-16

Rev-CLL

Phase 2 Terminated

27 enrolled 7 charts

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01127542 2011-12-05

RESPeCT

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, B-Cell